)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
AstraZeneca Pharma India
AstraZeneca Pharma India (506820) investor relations material
AstraZeneca Pharma India Q1 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 26/27 earnings summary10 Aug, 2026
Executive summary
Reported 30% year-over-year growth in total revenue from operations to INR 6,828 million for Q1 FY2026-27, driven by strong performance in Oncology, Biopharmaceuticals, and Rare Disease segments.
Achieved key regulatory approvals and advanced strategic partnerships, expanding access to innovative healthcare solutions in India.
Board approved unaudited financial results for the quarter ended June 30, 2026, and announced leadership changes including the appointment of Mr. Arun Krishna as Additional Director and change in designation for Ms. Bhavana Agrawal.
Financial highlights
Total revenue from operations for Q1 FY2026-27 was INR 6,828 million, up 30% year-over-year.
Profit before exceptional items and tax stood at INR 510 million; profit after exceptional items and tax was INR 507 million.
Earnings per share (basic and diluted) for the quarter were INR 15.17, compared to INR 22.33 in Q1 FY2025-26.
Oncology revenue grew 26%, Biopharmaceuticals 36%, and Rare Diseases 35x year-over-year.
Outlook and guidance
Focus remains on strategic investments to support sustainable long-term value creation and expanding access to innovative medicines.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from AstraZeneca Pharma India
- 33% revenue growth and robust profit, driven by innovation and new approvals in key therapy areas.506820
Q4 25/26 - Q3 FY25-26 revenue grew 39% year-over-year, driven by strong therapy area performance and innovation.506820Q3 25/26
- 32% revenue growth and robust product launches drive strong FY 2024-25 results.506820Q4 24/25
- Exceptional expense for site closure resulted in a quarterly net loss despite higher revenue.506820Q1 24/25
- Net profit declined due to a major provision for site closure, despite higher revenue.506820Q2 24/25
- Revenue surged 44% year-over-year in Q3 2024, led by Oncology and Biopharmaceuticals growth.506820Q3 24/25
- Q1 FY25-26 revenue up 36% YoY, profit after tax at ₹558.3M, four new therapy approvals.506820Q1 25/26
- Q2 revenue surged 37% year-over-year, with profit and new approvals boosting growth.506820Q2 25/26
Next AstraZeneca Pharma India earnings date
Q2 26/276 Nov, 2026
AstraZeneca Pharma India
Next AstraZeneca Pharma India earnings date
Q2 26/276 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage